TB:MEGA Mega Lifesciences Public Company Limited
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods. It operates through Brands, Distribution, and Original Equipment Manufacture segments. The company provides various complementary medicines for bone and joint, children, diabetic, herbal, heart, liver and digestive, skin, slimming, and well-being care, as well as men's and women's care products and sports supplements; gastrointestinal and pain care OTC medicines; and prescription medicines in the areas of iron supplement, anticoagulant, diabetology, cardiology, dermatology, gastroenterology, neurology, pain, osteoporosis, respiratory, urology, oncology, and nephrology. It also offers logistical and marketing services for the sale of goods manufactured by third parties. In addition, the company engages in the operation of wellness center; and software design, development, and other services business. Mega Lifesciences Public Company Limited exports its products to the Asia-Pacific, the Middle East, Africa, Latin America, and Europe, as well as the Commonwealth of Independent States. The company was founded in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited.
42.75 THB
As of 03/24/2023
Security Information
Category1: Global Equity
Category2: Common stocks
Category3: Emerging markets
GICS sector: Health Care
Industry: Drug Manufacturers-Specialty &
Index country: Thailand
Country of incorporation: Thailand
IPO date: 11/19/2013
Stock exchange: Stock Exchange Of Thailan
Exchange country: Thailand
Market cap: 46,209,110,016 THB
Current dividend yield: 1.62%
Sedol: BGLZX73